All News #Library
Others
Scenic Enters Agreement with National Institutes of Health for Genetic Treatment
01 Feb 2023 //
BUSINESSWIRE
Scenic Biotech Appoints Jens Würthner as Chief Medical Officer
24 Oct 2022 //
BUSINESSWIRE
Scenic Biotech and the Barth Syndrome Foundation Announce Partnership
30 Mar 2022 //
PRNEWSWIRE
$31M to progress pipeline of genetic modifiers in cancer and rare diseases
10 Mar 2022 //
PHARMAFILE

Market Place
Sourcing Support